carbamates has been researched along with Movement Disorders in 3 studies
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rivastigmine (2 mg/kg) reduced cerebral edema by at least 50% (p < 0." | 1.30 | Rivastigmine, a brain-selective acetylcholinesterase inhibitor, ameliorates cognitive and motor deficits induced by closed-head injury in the mouse. ( Chen, Y; Constantini, S; Shohami, E; Weinstock, M, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scheel-Krüger, J | 1 |
| Randrup, A | 1 |
| Chen, Y | 1 |
| Shohami, E | 1 |
| Constantini, S | 1 |
| Weinstock, M | 1 |
| Zelikovsky, A | 1 |
| Urca, I | 1 |
| Shaklai, M | 1 |
| de Vries, A | 1 |
1 trial available for carbamates and Movement Disorders
| Article | Year |
|---|---|
A clinical trial with pyridinolcarbamate in the treatment of patients with obstructive diseases of the peripheral arteries.
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Carbamates; Female; Femoral Artery; Gait; Human | 1973 |
2 other studies available for carbamates and Movement Disorders
| Article | Year |
|---|---|
Stereotype hyperactive behaviour produced by dopamine in the absence of noradrenaline.
Topics: Animals; Behavior, Animal; Brain Chemistry; Carbamates; Catecholamines; Dihydroxyphenylalanine; Dopa | 1967 |
Rivastigmine, a brain-selective acetylcholinesterase inhibitor, ameliorates cognitive and motor deficits induced by closed-head injury in the mouse.
Topics: Animals; Brain Edema; Carbamates; Cholinergic Antagonists; Cholinesterase Inhibitors; Cognition Diso | 1998 |